Skip to main content
OpenTrials

Clinical trial condition

Stomach Diseases

Explore clinical trials studying Stomach Diseases. Study availability and eligibility vary by location and protocol.

2,581 public trials 586 recruiting studies
Refine in advanced search Browse all conditions

Stomach Diseases trial results

Completed

FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer

NCT04768686

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Hanllym University Medical Center Anyang-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • The Catholic University of Korea St. Vincent Hospital Suwon, Gyeonggi-do, South Korea
  • Chonnam National University Hwasun Hospital Hwasun, Jeollanam-do, South Korea
View Trial Details
Completed

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

NCT05104567

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +29 more
Locations
  • City of Hope Site Number : 8400007 Duarte, California, United States
  • AdventHealth Orlando Site Number : 8400005 Orlando, Florida, United States
  • Seattle Cancer Care Alliance Site Number : 8400009 Seattle, Washington, United States
  • Investigational Site Number : 0560002 Brussels, Belgium
View all 29 locations
View Trial Details
Completed

A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy

NCT03813784

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Beijing Cancer Hospital, Peking University Beijing, Beijing Municipality, China
View Trial Details
Completed

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

NCT03929666

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +21 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 23 locations
View Trial Details
Completed

Study of ESG401 in Adults With Solid Tumors

NCT04892342

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +43 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China
  • The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China
View Trial Details

Related conditions